{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:26:50Z","timestamp":1792506410238,"version":"4.5.0"},"reference-count":34,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,8,23]]},"DOI":"10.1001\/jama.2022.13997","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T15:42:28Z","timestamp":1661269348000},"page":"728","source":"Crossref","is-referenced-by-count":185,"title":["Effect of Radiotherapy Alone vs Radiotherapy With Concurrent Chemoradiotherapy on Survival Without Disease Relapse in Patients With Low-risk Nasopharyngeal Carcinoma"],"prefix":"10.1001","volume":"328","author":[{"given":"Ling-Long","family":"Tang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, First People\u2019s Hospital of Foshan, Foshan Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Deng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, the Wuzhou Red Cross Hospital, Wuzhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Bin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People\u2019s China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Han","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao Hui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Princess Margaret Cancer Centre\/University of Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jun","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, First People\u2019s Hospital of Foshan, Foshan Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hui","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, the Wuzhou Red Cross Hospital, Wuzhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ming","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, the Wuzhou Red Cross Hospital, Wuzhou, Guangxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ping","family":"Mao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan-Qun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Pei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical Trials Centre, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Centre for Cancer Medicine, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Jing","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sun Yat-sen University Cancer Center, the State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong, China"},{"name":"Center for Precision Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"joi220089r1","doi-asserted-by":"publisher","first-page":"vii83","DOI":"10.1093\/annonc\/mds266","article-title":"Nasopharyngeal cancer: EHNS-ESMO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"23","author":"Chan","year":"2012","journal-title":"Ann Oncol"},{"issue":"23","key":"joi220089r2","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/jnci\/djr432","article-title":"Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.","volume":"103","author":"Chen","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"joi220089r3","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized intergroup study 0099.","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J Clin Oncol"},{"issue":"28","key":"joi220089r4","doi-asserted-by":"publisher","first-page":"6966","DOI":"10.1200\/JCO.2004.00.7542","article-title":"Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group.","volume":"23","author":"Lee","year":"2005","journal-title":"J Clin Oncol"},{"key":"joi220089r5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s12967-015-0729-0","article-title":"Value of the prognostic nutritional index and weight loss in predicting metastasis and long-term mortality in nasopharyngeal carcinoma.","volume":"13","author":"Du","year":"2015","journal-title":"J Transl Med"},{"issue":"7","key":"joi220089r6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068660","article-title":"High weight loss during radiation treatment changes the prognosis in under-\/normal weight nasopharyngeal carcinoma patients for the worse: a retrospective analysis of 2433 cases.","volume":"8","author":"Shen","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"joi220089r7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.radonc.2012.08.022","article-title":"Increased treatment-related mortality with additional cisplatin-based chemotherapy in patients with nasopharyngeal carcinoma treated with standard radiotherapy.","volume":"104","author":"Zhang","year":"2012","journal-title":"Radiother Oncol"},{"key":"joi220089r8","doi-asserted-by":"publisher","first-page":"17378","DOI":"10.1038\/srep17378","article-title":"Efficacy of concurrent chemotherapy for intermediate risk NPC in the intensity-modulated radiotherapy era: a propensity-matched analysis.","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"1","key":"joi220089r9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijrobp.2010.09.011","article-title":"Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.","volume":"82","author":"Su","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"joi220089r10","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3389\/fonc.2020.01314","article-title":"Adding concurrent chemotherapy to intensity-modulated radiotherapy does not improve treatment outcomes for stage II nasopharyngeal carcinoma: a phase 2 multicenter clinical trial.","volume":"10","author":"Huang","year":"2020","journal-title":"Front Oncol"},{"issue":"19","key":"joi220089r11","doi-asserted-by":"publisher","first-page":"7100","DOI":"10.1002\/cam4.v9.19","article-title":"Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinoma.","volume":"9","author":"Huang","year":"2020","journal-title":"Cancer Med"},{"issue":"2","key":"joi220089r12","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/COC.0b013e31828f5c96","article-title":"A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma.","volume":"38","author":"Pan","year":"2015","journal-title":"Am J Clin Oncol"},{"issue":"2","key":"joi220089r13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.ijrobp.2012.09.003","article-title":"Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.","volume":"86","author":"Li","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"joi220089r14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.radonc.2021.10.018","article-title":"Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort.","volume":"165","author":"Chin","year":"2021","journal-title":"Radiother Oncol"},{"key":"joi220089r15","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2021.01.015","article-title":"Unambiguous advanced radiologic extranodal extension determined by MRI predicts worse outcomes in nasopharyngeal carcinoma: potential improvement for future editions of N category systems.","volume":"157","author":"Mao","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1","key":"joi220089r16","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","article-title":"Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines.","volume":"110","author":"Gr\u00e9goire","year":"2014","journal-title":"Radiother Oncol"},{"issue":"11","key":"joi220089r17","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1002\/cac2.v41.11","article-title":"The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.","volume":"41","author":"Tang","year":"2021","journal-title":"Cancer Commun (Lond)"},{"issue":"5","key":"joi220089r18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10166","key":"joi220089r20","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial.","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"joi220089r21","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S1470-2045(18)30104-9","article-title":"Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.","volume":"19","author":"Tang","year":"2018","journal-title":"Lancet Oncol"},{"issue":"5","key":"joi220089r22","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/S1470-2045(21)00075-9","article-title":"Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.","volume":"22","author":"Lv","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"joi220089r23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044480","article-title":"Testing for non-inferior mortality: a systematic review of non-inferiority margin sizes and trial characteristics.","volume":"11","author":"Pong","year":"2021","journal-title":"BMJ Open"},{"issue":"2","key":"joi220089r24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.2307\/2531021","article-title":"Sample-size formula for the proportional-hazards regression model.","volume":"39","author":"Schoenfeld","year":"1983","journal-title":"Biometrics"},{"issue":"22","key":"joi220089r25","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1200\/JCO.2004.10.074","article-title":"The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature.","volume":"22","author":"Langendijk","year":"2004","journal-title":"J Clin Oncol"},{"issue":"1","key":"joi220089r26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijrobp.2005.06.037","article-title":"Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.","volume":"64","author":"Baujat","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"joi220089r27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0194733","article-title":"The role of concurrent chemotherapy for stage II nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: a systematic review and meta-analysis.","volume":"13","author":"Liu","year":"2018","journal-title":"PLoS One"},{"key":"joi220089r28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.oraloncology.2015.10.020","article-title":"Individualised quality of life as a measure to guide treatment choices in squamous cell carcinoma of the head and neck.","volume":"52","author":"Licitra","year":"2016","journal-title":"Oral Oncol"},{"issue":"11","key":"joi220089r29","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1634\/theoncologist.2016-0105","article-title":"Prognostic value of the cumulative cisplatin dose during concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a secondary analysis of a prospective phase III clinical trial.","volume":"21","author":"Peng","year":"2016","journal-title":"Oncologist"},{"issue":"3","key":"joi220089r30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.anl.2016.07.015","article-title":"The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.","volume":"44","author":"Kano","year":"2017","journal-title":"Auris Nasus Larynx"},{"issue":"9","key":"joi220089r31","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1002\/hed.v42.9","article-title":"Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.","volume":"42","author":"Verma","year":"2020","journal-title":"Head Neck"},{"issue":"4","key":"joi220089r32","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1002\/hed.v44.4","article-title":"Nasopharyngeal cancer: incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.","volume":"44","author":"Wu","year":"2022","journal-title":"Head Neck"},{"issue":"8","key":"joi220089r33","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1158\/1078-0432.CCR-12-3702","article-title":"An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma.","volume":"19","author":"Le","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"4","key":"joi220089r34","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/cncr.v122.4","article-title":"Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.","volume":"122","author":"Pan","year":"2016","journal-title":"Cancer"},{"key":"joi220089r19","volume-title":"EORTC QLQ-C30 Scoring Manual","author":"Fayers","year":"2001","edition":"3rd ed"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2795527\/jama_tang_2022_oi_220089_1660869435.868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T15:42:34Z","timestamp":1661269354000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2795527"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,8,23]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,23]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.13997","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,23]]}}}